InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Voliotis Dimitris, Vice-Président Senior, Développement clinique. Director active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 2 reports have been recorded. History available since 18 January 2022. The latest transaction was filed on 10 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Voliotis Dimitris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,329 shares0Common StockSEC:0001725160-22-000035:0
10,000 shares@ US$18.00100.0% of flowCommon StockSEC:0001725160-22-000015:0
2 of 2 declarations
About Voliotis Dimitris
Voliotis Dimitris is the Senior Vice President, Clinical Development at Zentalis Pharmaceuticals, Inc. He oversees clinical development programs and ensures compliance with regulations. His expertise in the pharmaceutical field is essential for the success of clinical trials and the development of new treatments. He plays a key role in the company's research and development strategy.
